283 related articles for article (PubMed ID: 36819342)
21. Diagnosis and screening of patients with hereditary angioedema in primary care.
Henao MP; Kraschnewski JL; Kelbel T; Craig TJ
Ther Clin Risk Manag; 2016; 12():701-11. PubMed ID: 27194914
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
23. Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance.
Li HH
Patient Prefer Adherence; 2016; 10():1727-37. PubMed ID: 27660422
[TBL] [Abstract][Full Text] [Related]
24. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
[TBL] [Abstract][Full Text] [Related]
25. Orthognathic Surgery in Hereditary Angioedema With Normal C1 Inhibitor: A Clinical Response to Concentrated C1 Inhibitor Against Angioedema Attack.
Watanabe T; Yamashita K; Bessho K
J Oral Maxillofac Surg; 2021 Feb; 79(2):463-470. PubMed ID: 32888936
[TBL] [Abstract][Full Text] [Related]
26. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
27. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
28. The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures.
Valerieva A; Cicardi M; Baraniuk J; Staevska M
Allergy Asthma Clin Immunol; 2018; 14():75. PubMed ID: 30386388
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
30. The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study.
Gavigan G; Yang WH; Santucci S; Harrison R; Karsh J
Allergy Asthma Clin Immunol; 2014; 10(1):17. PubMed ID: 24772176
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
32. Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.
Jones D; Zafra H; Anderson J
J Asthma Allergy; 2023; 16():447-460. PubMed ID: 37124440
[TBL] [Abstract][Full Text] [Related]
33. Hereditary angioedema with normal C1-INH (HAE type III).
Riedl MA
J Allergy Clin Immunol Pract; 2013; 1(5):427-32. PubMed ID: 24565612
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema with an acute attack resolved after bone marrow transplantation for acute myeloid leukemia: a case report.
Honda D; Ohsawa I; Aizawa M; Tomino Y; Asanuma K
Allergy Asthma Clin Immunol; 2023 May; 19(1):42. PubMed ID: 37194078
[TBL] [Abstract][Full Text] [Related]
35. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
36. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
Khan DA
Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
[TBL] [Abstract][Full Text] [Related]
37. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.
Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M
J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life among children with hereditary angioedema.
Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
